{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:36:56Z","timestamp":1793371016475,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019871","name":"Castle Biosciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.08.075","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:34:39Z","timestamp":1787614479000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma"],"prefix":"10.1016","author":[{"given":"D\u00e9sir\u00e9e","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Farberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally-Khan","family":"Somani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav N.","family":"Tolkachjov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T.","family":"Arron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.08.075_bib1","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Squamous Cell Skin Cancer V.2.2026","author":"Bordeaux","year":"2026"},{"key":"10.1016\/j.jaad.2026.08.075_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s13555-025-01470-7","article-title":"A comprehensive narrative review of the challenges surrounding cutaneous SCC","volume":"15","author":"Beach","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/bjd\/ljad425","article-title":"International patterns and trends in the incidence of melanoma and cutaneous squamous cell carcinoma, 1989-2020","volume":"190","author":"Olsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bjd\/ljad480","article-title":"Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention","volume":"190","author":"Eggermont","year":"2024","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.075_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: a nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.075_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma outcomes: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamaoto.2018.4515","article-title":"Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional lymph node metastasis: a systematic review and meta-analysis","volume":"145","author":"Sahovaler","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.075_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjoto.2017.01.035","article-title":"Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient","volume":"38","author":"McLaughlin","year":"2017","journal-title":"Am J Otolaryngol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.075_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on cancer staging manual, 8th edition vs the Brigham and Women's Hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib11","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/hed.28259","article-title":"Validation of current staging systems in HNCSCC: a multinational cohort study","volume":"47","author":"Girardi","year":"2025","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2026.08.075_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40257-025-00987-z","article-title":"Performance of staging systems for non-head and neck cutaneous squamous cell carcinoma","volume":"27","author":"Voller","year":"2026","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.075_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamadermatol.2023.1353","article-title":"Validation of the 2022 national comprehensive cancer network risk stratification for cutaneous squamous cell carcinoma","volume":"159","author":"Stevens","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.25251\/mvr2rn83","article-title":"The 40-gene expression profile test identifies patients with national comprehensive cancer network high-risk cutaneous squamous cell carcinoma at high risk of poor outcomes to inform management decisions","volume":"9","author":"Ratner","year":"2025","journal-title":"J Skin"},{"key":"10.1016\/j.jaad.2026.08.075_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaad.2024.05.014","article-title":"Limitations of the commercially available gene expression test in predicting cutaneous squamous cell carcinoma metastasis and clinical outcomes","volume":"93","author":"Sax","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.075_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaad.2025.02.092","article-title":"Re: limitations of the commercially available gene expression test in predicting cutaneous squamous cell carcinoma metastasis and clinical outcomes","volume":"93","author":"Goldberg","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2026.08.075_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/DSS.0000000000004324","article-title":"Commentary on \u201cClinical versus histologic margins for cutaneous squamous cell carcinoma: comparing outcomes for high-risk tumors treated with Mohs micrographic surgery.\u201d","volume":"50","author":"Tolkachjov","year":"2024","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.25251\/83v2hr07","article-title":"Actionable risk thresholds for adjuvant radiation therapy and surveillance imaging in high-risk cutaneous squamous cell carcinoma","volume":"9","author":"Shah","year":"2025","journal-title":"J Skin"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.075_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cam4.4426","article-title":"Cutaneous squamous cell carcinoma staging may influence management in users: a survey study","volume":"11","author":"Patel","year":"2022","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.075_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2025.02.076","article-title":"riSCC: a personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma","volume":"93","author":"Jambusaria-Pahlajani","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2025.05.1390","article-title":"Enhanced metastatic risk stratification for cutaneous squamous cell carcinoma by combining clinical guidelines with the Erasmus MC model: results from two nationwide nested case-control studies","volume":"93","author":"Steijlen","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.075_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jaad.2021.11.046","article-title":"Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes","volume":"86","author":"Gupta","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102150","article-title":"Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model","volume":"63","author":"Rentroia-Pacheco","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.075_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamadermatol.2024.6214","article-title":"Mohs surgery vs wide local excision in primary high-stage cutaneous squamous cell carcinoma","volume":"161","author":"Wang","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.075_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ijrobp.2024.05.022","article-title":"Association of a 40-gene expression profile with risk of metastatic disease progression of cutaneous squamous cell carcinoma and specification of benefit of adjuvant radiation therapy","volume":"120","author":"Arron","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.jaad.2026.08.075_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2020.04.088","article-title":"Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma","volume":"84","author":"Wysong","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"35","key":"10.1016\/j.jaad.2026.08.075_bib24","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1080\/14796694.2024.2390820","article-title":"Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile","volume":"20","author":"Ruiz","year":"2024","journal-title":"Future Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2026.08.075_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/fon-2021-1277","article-title":"Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test","volume":"18","author":"Ibrahim","year":"2022","journal-title":"Future Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2026.08.075_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13555-024-01111-5","article-title":"Integrating the 40-gene expression profile (40-GEP) test improves metastatic risk-stratification within clinically relevant subgroups of high-risk cutaneous squamous cell carcinoma (cSCC) patients","volume":"14","author":"Wysong","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2026.08.075_bib27","article-title":"Gene expression profiling (GEP) in dermatology, part 1: introduction, development, benefits, limitations, and future directions of GEP","author":"Mehrmal","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jid.2025.11.001","article-title":"Comparative analysis of staging and metastatic risk stratification systems for cutaneous squamous cell carcinoma","volume":"146","author":"Bapna","year":"2026","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib29","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s13555-024-01125-z","article-title":"Inconsistent associations between risk factor profiles and adjuvant radiation therapy (ART) treatment in patients with cutaneous squamous cell carcinoma and utility of the 40-Gene expression profile to refine ART guidance","volume":"14","author":"Moody","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"10.1016\/j.jaad.2026.08.075_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/DSS.0000000000002923","article-title":"A histopathologic scoring system for perineural invasion correlates with adverse outcomes in patients with cutaneous squamous cell carcinoma","volume":"47","author":"Totonchy","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.08.075_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2025.10.054","article-title":"Risk of recurrence, metastasis, and death for cutaneous squamous cell carcinomas with solitary large caliber perineural invasion: a multicenter cohort study","volume":"94","author":"Ran","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"3 Suppl 2","key":"10.1016\/j.jaad.2026.08.075_bib33","first-page":"S3","article-title":"Integrating 40-GEP testing to improve clinical recommendations for adjuvant radiation for cutaneous squamous cell carcinoma: multidisciplinary consensus guidelines","volume":"17","author":"Gopal","year":"2024","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2022.05.043","article-title":"What causes the death of patients with cutaneous squamous cell carcinoma? A prospective analysis in 1400 patients","volume":"172","author":"Eigentler","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2026.08.075_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.08.075_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaad.2022.06.1169","article-title":"Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: an analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death","volume":"88","author":"Soleymani","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.08.075_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamadermatol.2026.0803","article-title":"Diagnostic modalities and nodal staging in high-risk cutaneous squamous cell carcinoma","volume":"162","author":"Ferr\u00e1ndiz-Pulido","year":"2026","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.08.075_bib40","doi-asserted-by":"crossref","first-page":"502","DOI":"10.36849\/JDD.9564","article-title":"Predicting benefit of adjuvant radiation therapy for cutaneous squamous cell carcinoma: a systematic review","volume":"25","author":"Burshtein","year":"2026","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226033979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226033979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:27:32Z","timestamp":1793370452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226033979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S0190962226033979"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.075","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.08.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}